The
Promise of
Interleukin-2
Therapy

14-17 Sept. 2022

for autoimmune and inflammatory diseases, allergy, transplantation and cancer

Auditorium
Centre international de Conférences Sorbonne Université

4 place Jussieu, Patio 44-55

75005 - Paris, France

*To submit before June 30, 2022
 
*For late breakers, please send an email to il2.congress.2022@gmail.com
logoinserm.png
logo-desktop-white_edited.png
logoAPHP.png
logoiltoo.png
logoINRA.png

Confirmed Speakers

(by alphabetical order)

Abul K. Abbas, Stanley Appel, Christophe Benoist, Jeff Bluestone, Onur Boyman, Frederic de Blay, Jason Fontenot, Ron Germain, Agnes Hartemann, Jens Humrich, John Koreth, David Klatzmann, Emmanuelle Le Chatelier, Warren Leonard, Matteo Levisetti, Zhanguo Li, Adrian Liston, Catherine Lubetzki, Ziad Mallat, Diane Mathis, Arsene Mekinian, Thomas Malek, Steven Quayle, Aleksander Rudensky, Shimon Sakaguchi, Scott Snapper, Mary Struthers, Nadia Tchao, Georges Tsokos, Thomas Vazquez, Lucy Walker, Jonathan Zalevsky

 

2022 Preliminary Agenda

Wed. 14th
Thu. 15th
Fri. 16th
Sat. 17th

Wed. 14

Thu. 15

Fri. 16

Sat. 17

6.00 pm

Opening Sessions
Keynote lectures

9.00 am

Session I
On mechanistic aspects
 

9.00 am

Session IV.b
Lessons form current clinical trials with
native IL-2
 

9.00 am

Session VIII
IL-2 and Treg cell therapies: competing or complementing
 

8.00 pm

Coffee Break

Coffee Break

Coffee Break

Welcome reception

Session II
On mechanistic aspects
 

Session V
iMAP
 

Session VI.b
Novel IL-2s in development

Lunch & posters

Lunch & posters

1.00 pm

2.30 pm

Session II
On mechanistic aspects
 

Coffee Break

Session IV.a
Lessons from current clinical trials with plain IL-2
 

2.30 pm

Session VI.a
Clinical trial results from Novel IL-2s

Coffee Break

Session VII
IL-2 in cancer therapy
 

End of the day

6.30 pm

Drinks and posters

7.30 pm

End of the day

6.30 pm

Drinks and posters

7.30 pm

End of the day

 
 

2022 Agenda

 

Click for details

Wed. 14

Thu. 15

Fri. 16

6.00 pm

Opening Session
Keynote lectures

8.00 pm

Welcome reception

9.00 am

Session I
On mechanistic aspects: IL-2, receptors and signaling

Coffee Break

Session II
On mechanistic aspects: physiology and pathophysiology

Lunch & posters

2.00 pm

Session III
On mechanistic aspects: physiology and pathophysiology

Coffee Break

Session IV
Lessons from current clinical trials with native IL-2
 

6.00 pm

9.00 am

Session V
Treg targeted IL-2 muteins in clinical trials

Coffee Break

Session VI

Biomarkers of IL-2 therapeutic effects: iMAP outcomes

Lunch & posters

2.00 pm

Session VII

IL-2 and Treg cell therapies: competing or complementing?

Coffee Break

Session VIII
Round table: the promise of IL-2 and IL-2 muteins in autoimmune and inflammatory diseases

6.00 pm

Sat. 17

9.00 am

Session IX
IL-2 in cancer therapy

Coffee Break

Session X

Novel IL-2s and combination therapies

1.30 pm

End of the meeting

Drinks and posters

7.30 pm

End of the day

Drinks and posters

7.30 pm

End of the day

 Partners

logoAPHP.png
logo_BCLS_Vertical.jpg
logoiltoo.png
logoICM.png
logoINRA.png
logo-desktop-white_edited.png

Sponsors

nektar logo.jpeg
02852_MSD_Logo_W_Anthem_Horizontal_TealGrey_RGB (1).jpg
Sangamo-logoTM_Transparent.png
logosorbonne.png
211125_SANOFI_LOGO_RGB.jpg
CUE Logo Horizontal © 2016SEP27 V600.jpg
 
 

The venue

Centre international de conférences Sorbonne Université

4, place Jussieu

75005, Paris

France